丹参酮ⅡA磺酸钠在慢性阻塞性肺疾病中的作用及其机制研究进展
摘要
关键词
全文:
PDF (English)参考
Fischer B M , Pavlisko E , Voynow J A . Pathogenic triad in COPD: Oxidative stress, protease-antiprotease imbalance, and inflammation[J]. International Journal of COPD, 2011(01):413-421.
Zhang, K., et al., Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells. Am J Physiol Cell Physiol, 2014(01):59-65.
Jiang, Q., et al., Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-gamma signaling axis[J]. Am J Physiol Cell Physiol, 2016(01):136-149.
Huang, L., et al., Tanshinone IIA attenuates cardiac dysfunction in endotoxin-induced septic mice via inhibition of NADPH oxidase 2-related signaling pathway[J]. International Immunopharmacology, 2015(01):444-449.
张伟,谷明明,孙璐璐,等.COPD大鼠肺血管重构与气管重塑的实验研究[J].安徽医科大学学报,2013(03):245-248.
李春陵,朱静雯,王里.丹参酮ⅡA磺酸钠对慢性阻塞性肺疾病气道重塑大鼠PPARγ、NF-κB的影响研究[J].贵州医药,2016(05):466-468.
郑权,田景伦,刘霞,等.吸烟对慢性阻塞性肺病患者血清IL.1B和IL-lRa的影响[J].标记免疫分析与临床,2008(06):346:348.
刘霞,田景伦,何书经,等.丹参酮ⅡA对慢性阻塞性肺疾病患者血清白介素-1β和白介素-1受体拮抗剂的影响[J].中国老年学杂志,2013(01):32-33.
Yagi, O., K. Aoshiba and A. Nagai, Activation of Nuclear Factor-κB in Airway Epithelial Cells in Patients with Chronic Obstructive Pulmonary Disease. Respiration, 2006(05):610-616.
Cronin JG,Turner ML,Goetze L,et al.Toll—like receptor 4 and MYD88-dependent signaling mechanisms of the in-nate immune system are essential for the response to lipopolysaecharide by epithelial
and stromal ceHs of the bovine endometrium[J].Biol Reprod,
(02):51.
俞凌,陈晔.丹参酮ⅡA对COPD模型大鼠肺组织炎症反应的影响及相关机制研究[J].浙江中西医结合杂志,2018(01):4-8.
Esmon C T . Crosstalk between inflammation and thrombosis.[J]. Maturitas, 2004(04):305-314.
王静,杨宝江,常银竹,等.参附注射液联合丹参酮ⅡA磺酸钠注射液治疗慢性阻塞性肺疾病急性加重期[J].吉林中医药,2015(07):696-699+700.
吴晓莲.肺部疾病患者血浆D-二聚体水平的变化及意义[J].临床肺科杂志,2007(11):1168.
DOI: http://dx.doi.org/10.26549/yzlcyxzz.v3i8.6239
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。